Semaglutide (brand names Ozempic for diabetes, Wegovy for obesity) and tirzepatide (Mounjaro for diabetes, Zepbound for obesity) can produce dramatic weight loss (averaging ~1520% in clinical trials ( [11] )) and lower cardiovascular risk
Heres what happens: Comprehensive health evaluation We review your medical history, current medications, previous weight loss attempts, and whats been working or not working for you
And the diet can still be expensive for meat eaters
After complete surgical excision, the local-regional relapse rate is reported to be 10-20%, and 5-year survival rates are clustered around 10-25%, with a reported range of 4.5-48%
Dei, S., Braconi, L., Romanelli, M